Raziel Therapeutics

Developing a proprietary drug for the treatment of local fat reduction

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2012 language raziel-therapy.com

Innovation

9 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 214 times.

YearFilings
20162
20181
20201
20213
20226
20235
20247
20252

Investor mix

11 investors on record; lead investors include Pontifax.

Investor typeCountShare
Venture capital764%
Private equity19%
Angel & family office19%
Other / undisclosed218%
Coming soon